| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/18/2009 | US7576239 Substituted amides |
| 08/18/2009 | US7576234 Synthesis of 2-alkyl amino acids |
| 08/18/2009 | US7576226 oximation of d-norgestrel to form d-(17 alpha )-13-ethyl-17-hydroxy-18,19-dinorpregn-4-ene-20-yn-3-one-3E- and -3Z-oxime isomers, used as contraceptives; hormone replacement therapy |
| 08/18/2009 | US7576225 isolated from the Caenorhabditis elegance related to suppress of aging and stress |
| 08/18/2009 | US7576221 Substituted imidazole derivatives |
| 08/18/2009 | US7576218 1-[2-(4-chloro-5-methyl-3-trifluoromethyl-pyrazol-1-yl)-acetyl]-4-(4-chloro-phenyl)-piperidine-4-carbonitrile; -[2-(4-chloro-5-methyl-3-trifluoromethyl-pyrazol-1-yl)-acetyl]-4-(4-chloro-phenyl)-piperidine-4-carboxylic acid methyl ester; deposited on a stent or stent-graft device |
| 08/18/2009 | US7576215 Anticholesterol agents; antidiabetic agents; cardiovascular disorders ; antiarthritic agents |
| 08/18/2009 | US7576204 (8E,12E,14E)-21-benzoyloxy-3,6-dihydroxy-6,10,12,16,20-pentamethyl-7-((4-methylpiperazin-1-yl)carbonyl)oxy-18,19-epoxytricosa-8,12,14-trien-11-olide; inhibits angiogenesis and inhibits the production of VEGF particularly under hypoxic conditions, which makes it useful as a remedy for solid cancer |
| 08/18/2009 | US7576200 Diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use |
| 08/18/2009 | US7576196 siRNA targeting transducin (beta)-like 3 (TBL3) |
| 08/18/2009 | US7576135 Cyclic diamine derivatives useful as agents for preventing and/or treating cerebral infarction, cerebral embolism, myocardial infarction, angina pectoris, pulmonary infarction, pulmonary embolism; inhibit activated blood coagulation factor X |
| 08/18/2009 | US7576133 Stimulants; narcolepsy therapy |
| 08/18/2009 | US7576132 Bone/cartilage disorders; decreasing insulin resistance |
| 08/18/2009 | US7576131 Administering 2-acetamidoethyl 4-chlorophenyl-(3-trifluoro-methylphenoxy)acetate, as antidiabetic agents |
| 08/18/2009 | US7576130 Tetramethyltetradecanetetraols as anticarcinogenic, anticholesterol, antidiabetic and hypotensive agents; metabolic disorders, peroxisome proliferator activated receptor associated disorder, Alzheimer's Disease, obesity, pancreatitis; increased HDL levels and lowers LDL levels; combination therapy |
| 08/18/2009 | US7576129 Carboxylic acid compounds |
| 08/18/2009 | US7576128 4-oxy-benzonitriles e.g. (1S,4S)-4-(4-Hydroxy-1-methylpentyloxy)-2-trifluoromethylbenzonitrile; acne, alopecia, and oily skin; early puberty, premenstrual syndrome, lung cancer, osteoporosis, hypogonadism, age-related muscle mass decline, hormone-dependent cancer |
| 08/18/2009 | US7576127 Aromatic prodrugs of propofol, compositions and uses thereof |
| 08/18/2009 | US7576126 Platinum (II) complexes, preparation and use |
| 08/18/2009 | US7576125 Piperonyl alcohol; storage stability |
| 08/18/2009 | US7576124 Anti-first-pass effect compounds |
| 08/18/2009 | US7576123 Anti-first-pass effect compounds |
| 08/18/2009 | US7576122 Ophthalmic compositions for treating ocular hypertension |
| 08/18/2009 | US7576121 Antidiabetic agenst |
| 08/18/2009 | US7576120 Azabicyclic compounds, a process for their preparation and pharmaceutical compositions containing them |
| 08/18/2009 | US7576119 Supports such as glass and styrene polymers functionalized with tricyclic hetercyclic anhydrides and imides, used in the preparation of oligonucleotides |
| 08/18/2009 | US7576118 Asymmetric hydrogenation process |
| 08/18/2009 | US7576117 Cyclic amine CCR3 antagonist |
| 08/18/2009 | US7576116 PDK-1/Akt signaling inhibitors |
| 08/18/2009 | US7576115 1-methyl,3-alkaminothiocarbonylhydrazonomethyl,4-hydroxy,5-phenyl pyrazole; low-molecular-weight, nonpeptidic thrombopoietin receptor agonist; oral administration; bioavailability; blood disorders; platelet-increasing agents; angiogenesis; arteriosclerosis; blood/stem cell stimulant; thrombocytopenia |
| 08/18/2009 | US7576114 6-(4-Bromo-2-chloro-phenylamino)-3H-benzoimidazole-5-carboxylic acid (2-hydroxy-ethoxy)-amide; anticarcinogenic, antiproliferative, and antiinflammatory agents; mitogen-activated protein kinase inhibitors |
| 08/18/2009 | US7576113 Use of (E)-5-(4-chlorbenzyliden)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl) cyclopentanol for combating rust attacks on soya plants |
| 08/18/2009 | US7576112 Therapeutic N-aryl or N-heteroaryl pyrazolidine and pyrazolidinone derivatives |
| 08/18/2009 | US7576111 Substituted oxazolidinones and their use in the field of blood coagulation |
| 08/18/2009 | US7576110 Benzothiazole cyclobutyl amine derivatives |
| 08/18/2009 | US7576109 5-{4-[4-Methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethoxy]-phenyl}-3H-[1,3,4]oxadiazol-2-one; agonists and antiagonists; demylination diseases; metabolic diseases; antidiabetic agents (type 2); syndrom X; asthma; osteoarthritis; lupus; antiinflammatory agents; cardiovascular disorders; cachexia |
| 08/18/2009 | US7576108 Substituted arylcyclopropylacetamides as glucokinase activators |
| 08/18/2009 | US7576106 2-(4-Chloro-5-methyl-3-trifluoromethyl-pyrazol-1-yl)-1-[4-(4-fluorobenzyl),4-hydroxypiperidin-1-yl]ethanone; potent chemokine receptor antagonists; antiinflammatory agents; immunotherapy; rheumatic diseases; antiarthritic agents; transplant rejection; multiple sclerosis |
| 08/18/2009 | US7576105 Benzyl substituted (piperidin-4-yl)aminobenzamido derivatives |
| 08/18/2009 | US7576104 4-(Aminomethyl)-2-(2,6-dioxo(3-piperidyl))isoindoline-1,3-dione hydrochloride; cytokines level reduced; tumor necrosis factor inhibitors; nontoxic; anticarcinogenic agents; antitumor agents (solid/blood-borne); cardiovascular disorders; osteoporosis; antiinflammatory agents; autoimmune diseases |
| 08/18/2009 | US7576103 Tetralin and indane derivatives and uses thereof |
| 08/18/2009 | US7576102 Biaryl substituted nitrogen containing heterocycle inhibitors of LTA4H for treating inflammation |
| 08/18/2009 | US7576101 Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents |
| 08/18/2009 | US7576100 Muscarinic agonists |
| 08/18/2009 | US7576099 inflammation-related conditions in mammals, arthritis, Parkinson's/Alzheimer's diseases, stroke, asthma; acute/chronic or neuropathic pain; VR1 agonist/antagonist; N-(2,3-Dihydro-benzo[1,4]dioxin-6-yl)-4-((E)-3,3-dimethyl-but-1-enyl)-benzamide; 6-(3,3-Dimethyl-but-1-ynyl)-N-guinolin-3-yl-nicotinamide |
| 08/18/2009 | US7576098 4-((3-Ethoxy-4-isopropoxyphenyl)(1H-imidazol-2-yl)methylamino)benzamidine; serine protease enzyme inhibiters; anticoagulants; kallikrein inhibitors; antithrombins; antiinflammatory agents; angina pectoris; myocardium infarction; antiischemic agents; bioavailability; side effect reductioncost efficiency |
| 08/18/2009 | US7576097 Crystalline form of maraviroc |
| 08/18/2009 | US7576096 Muscarinic acetylcholine receptor antagonists |
| 08/18/2009 | US7576095 2-(p-Alkoxy- or p-fluoroalkylsulonyloxyphenyl)-1-phenyl-5-cyclohexyl- or 5-(1-piperdinyl)-4,5-dihydropyrrolo[3,2-c]pyridin-4-ones; treatment of obesity, psychiatric and neurological disorders |
| 08/18/2009 | US7576094 5,7,8-Trimethyl-3,4-dihydrospiro[chromene-2,1'-cyclobutan]-6-ol; also analogous thiochromenes; antiapoptosis; anticarcinogenic agents; antihypoxic agents; anoxia; antiinflamatory agents; central nervous system disorders; autoimmune diseases; neurodegenerative disorders |
| 08/18/2009 | US7576093 Method of treatment of bone-related disorders or conditions |
| 08/18/2009 | US7576092 Benzofuro- and benzothienopyrimidine modulators of the histamine H4 receptor |
| 08/18/2009 | US7576091 Thiazolo-, oxazalo and imidazolo-quinazoline compounds capable of inhibiting protein kinases |
| 08/18/2009 | US7576090 Benzazole analogues and uses thereof |
| 08/18/2009 | US7576089 CCR2 or CCR5 receptor antagonists; atherosclerosis, restenosis, lupus, organ transplant rejection and rheumatoid arthritis, cancer, multiple sclerosis, HIV infection; e.g. N-(2-((3S)-3-[(4-Hydroxy-4-phenylcyclohexyl)amino]pyrrolidin-1-yl)-2-oxoethyl)-3-(trifluoromethyl)benzamide |
| 08/18/2009 | US7576088 Benzodioxole derivatives |
| 08/18/2009 | US7576087 3-(Phenylsulfonyl)-7-piperazin-1-yl-1H-pyrazolo[4,3-b]pyridine; 5-HT receptor subtype 5HT6; selective serotonin receptor antagonist; cognition actiators; alzheimer's disease; attention deficit disorder; antidepressant; antiepileptic agent; anxiolytic agents; obsessive compulsive disorder; Parkinson's |
| 08/18/2009 | US7576086 N1-benzyl-N4-(phenylpropane-2-yl-3-ol)piperazine; triple action on hydroxytryptamine (5-HT), noradrenalin (NA)and dopamine(DA); on brain synapses; cytochrome P-450 monooxygenase enzyme system antagonists; enzyme inhibitors; side effect reduction |
| 08/18/2009 | US7576085 Imidazo[1,2-a]pyrazine compounds; cancers |
| 08/18/2009 | US7576084 1-(Phenylmethylaminocarbonyl-),4,7-di(oxo-),6-(4-(hydroxylphenyl),8-(piperidino(1,3-phenylene)methyl)-perhydro(pyrazino(2,1-c)-as-triazine); disorders modulated by Wnt-signaling pathway; anticarcinogenic agents; colorectal cancer; restenosis; polycystic kidney disease; angiogenesis inhibition |
| 08/18/2009 | US7576083 2,4-dichloro-N-{[1- (isopropylsulfonyl)-4- (morpholine-4- ylcarbonyl)piperidin-4- yl]methyl}benzamide; selective GlyT1 uptake inhibitors; nervous system, psychological disorders; cognition activators; dementia; schizophrenia; Parkinson's/Alzheimer diseases;bipolar disorders; neuroleptic agents |
| 08/18/2009 | US7576082 rac-6-Chloro-3-(3-chloro-benzyl)-3-(1-methyl-1H-pyrazol-4-yl)-1,3-dihydro-indol-2-one; murine double minute (MDM2 ) oncogene inhibitor; feedback control loop of p53 mutant cells; inhibit the interaction between p53 and MDM2 proteins |
| 08/18/2009 | US7576081 Morpholine dopamine agonists |
| 08/18/2009 | US7576080 N-[3-(3-{[5-(4-Fluorophenyl)thieno[2,3-d]pyrimidin-4-yl]oxy}propoxy)phenyl]cyclopropanecarboxamide; PDE10 inhibitor; psychological, nervous system disorders; schizophrenia; cognition activators; drug abuse; antiepileptic agents; lupus; antitumor, -carcinogenic agents; hyperglycemica agents; sarcoidosis |
| 08/18/2009 | US7576079 Viral polymerase inhibitors |
| 08/18/2009 | US7576078 Tetrahydroquinoline analogues as muscarinic agonists |
| 08/18/2009 | US7576077 9-{[5-(3-Chlorophenyl)-1,2,4-oxadiazol-3-yl]methyl}-3-pyridin-4-yl-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a][1,3]diazepine; Group 1 receptor subtype; analgesics; psychological disorders; gastroesophageal reflux; neuroprotectans; antiischemic agents; hyperglycemic agents; neurodegenerative disease |
| 08/18/2009 | US7576076 1-Methyl,2,6-dioxo,4-(4-(ethyloxycarbony)piperazin-1-yl-),5-(3-trifluoromethylphenyl)methyl-)-1,2,3,6-tetrahydropyrimidine; antagonist, antagonism; psychoses; antidepressants; schizophrenia; psychological disorders; Alzheimer's disease; neurodegenerative diseases;drug abuse, drug dependence (cocaine) |
| 08/18/2009 | US7576074 Receptor-type kinase modulators and methods of use |
| 08/18/2009 | US7576073 Treating motor symptom(s), locootor activity, by concomitantly administering dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a dopamine precursor, such as levodopa; potentiation; antispasmodic agents; neurogenerative diseases; Alzheimer's; side effect reduction |
| 08/18/2009 | US7576072 Heterocyclic inhibitors of MEK and methods of use thereof |
| 08/18/2009 | US7576071 Antithrombotic compound |
| 08/18/2009 | US7576070 for inhibiting galectin-3- mediated cell-cell and/or cell-matrix Interactions leading to tumor diseases; hydrolyzing enzyme A |
| 08/18/2009 | US7576069 antiinflammatory agents 5-[6-Amino-2-(2-hydroxy-bicyclo[2.2.1]hept-2-ylethynyl)-purin-9-yl]-3,4-dihydroxy-tetrahydro-furan-2-carboxylic acid cyclopropylamide; futher comprising a Type IV phosphodiesterase inhibitor rolipram, cilomilast, or roflumilast; caused by E. Coli; treating cardiovascular disorders |
| 08/18/2009 | US7576068 Administration of TLR7 ligands and prodrugs thereof for treatment of infection by hepatitis C virus |
| 08/18/2009 | US7576067 Pulsatile release compositions and methods for enhanced intestinal oligonucleotide drug absorption |
| 08/18/2009 | US7576066 Administering nucleic acid to stimunlate immunology response |
| 08/18/2009 | US7576064 Pyrazole derivative, drug composition containing the same and production intermediate therefor |
| 08/18/2009 | US7576063 prevention or treatment of disease associated with hyperglycemia: diabetes, impaired glucose tolerance, impaired fasting glycemia, diabetic complications or obesity; e.g. 4-[(4-{3-[1-carbamoyl-1-(methyl)-ethylcarbamoyl]propyl}-2-methylphenyl)methyl]-3-( beta -D-glucopyranosyloxy)-5-isopropyl-1H-pyrazole |
| 08/18/2009 | US7576055 Comprised of three lipid elements: phosphatidyl choline, fatty-acyl-cholesterol esters, and at least one apolipoprotein; brain disorders; kits; efficiently target and deliver substances |
| 08/18/2009 | US7576053 Methods and compositions for treating degenerative bone disorders |
| 08/18/2009 | US7575923 CD19xCD3 specific polypeptides and uses thereof |
| 08/18/2009 | US7575918 GENETIC ENGINEERED nucleic acid, VECTOR CODING ANTISENSE AGENTS; FOR USE IN KILLING PREFERENTIAL TARGET CELLS OR MICRORGANISMS; biodrugs as antitumor agent, bactericides, anticarcinogenic agent; target on antibiotic resistant bacteria, drug-resistant cancer cells |
| 08/18/2009 | US7575886 Analysis of sulfated polysaccharides |
| 08/18/2009 | US7575767 Extraction of palm vitamin E, phytosterols and squalene from palm oil |
| 08/18/2009 | US7575762 Composition comprises sustained-release fine particles and manufacturing method thereof |
| 08/18/2009 | US7575760 Vitamin tablet enhancing appetite and calcium absorption; comprising a vitamin, lysine or a pharmaceutically acceptable salt thereof, a sweetener, and a pharmaceutically or dietetically acceptable carrier |
| 08/18/2009 | US7575757 Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof |
| 08/18/2009 | US7575755 Method of inducing an immune response to a parasite utilising an immunogenic composition comprising a glycosylphosphatidylinositol (referred to herein as "GPI") inositolglycan domain or its derivative or equivalent |
| 08/18/2009 | US7575743 Removing a portion of synovial membrane tissue from the animal; and filling the cartilage defect with the synovial membrane tissue. |
| 08/18/2009 | US7575742 Method of treating autoimmune diseases with interferon-beta and IL-2R antagonist |
| 08/18/2009 | US7575740 Applying to the tissue formulation comprising first precursor component second precursor component comprises electrophilic component which crosslink at physiological temperatures over a period of time following application |
| 08/18/2009 | US7575577 Devices and methods for the restoration of a spinal disc |
| 08/18/2009 | CA2585557C Pyrazolo[4,3-d] pyrimidine derivatives useful as pde-5 inhibitors |
| 08/18/2009 | CA2577233C Pharmaceutical composition containing angiotensin ii antagonist |
| 08/18/2009 | CA2549479C Substituted arylpyrazoles as parasiticidal agents |
| 08/18/2009 | CA2548739C Uv-stable, liquid or semisolid transdermal administration form comprising a photosensitive active ingredient |
| 08/18/2009 | CA2505500C Method of stimulating hair growth using benzopyrans |
| 08/18/2009 | CA2495721C Non-nucleoside reverse transcriptase inhibitors |
| 08/18/2009 | CA2481591C Stabilized ascorbic acid derivatives |